# CPAP in Treating Obstructive Sleep Apnea in Patients With Polycythemia Vera or Essential Thrombocythemia

> **NCT03972943** · EARLY_PHASE1 · TERMINATED · sponsor: **University of Utah** · enrollment: 8 (actual)

## Conditions studied

- CALR Gene Mutation
- Essential Thrombocythemia
- JAK2 Gene Mutation
- MPL Gene Mutation
- Obstructive Sleep Apnea Syndrome
- Polycythemia Vera

## Interventions

- **PROCEDURE:** Continuous Positive Airway Pressure
- **OTHER:** Patient Observation
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT03972943
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-05-15
- **Primary completion:** 2023-07-28
- **Final completion:** 2023-07-28
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Study terminated due to lack of funding
- **Last updated:** 2024-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03972943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03972943, "CPAP in Treating Obstructive Sleep Apnea in Patients With Polycythemia Vera or Essential Thrombocythemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03972943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*